Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Odysight.ai Inc.ODYS · Entity 7081 | Chief Business Officer | February 19, 2026 | February 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Odysight.ai Inc.
Report date February 19, 2026 · Filed February 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options to purchase common stock (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.14 · Expires 2036-02-19 | Direct | 15,000 |
Reported balance
After 2026-02-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-19 · Grant · Acquired 15,000 · Balance 15,000 F1: The stock option vests and becomes exercisable as to one-third of the total shares on November 15, 2026 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on November 15, 2028. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option vests and becomes exercisable as to one-third of the total shares on November 15, 2026 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on November 15, 2028.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2026 Filed Feb 23, 2026 21:05 UTC | Odysight.ai Inc. ODYS · Entity 7081 | GrantOptions to purchase common stock (right to buy) · Derivative | 15,000 | $0.00 Strike: $5.14 | $0.00 |
DisclosureSEC source: 0001493152-26-007749 · ownership.xml · derivative · entry 1 Sagi Eilam · CIK 0002097296 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2036-02-19 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to one-third of the total shares on November 15, 2026 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on November 15, 2028. Read SEC document |
| January 25, 2026 Filed Jan 27, 2026 21:05 UTC | Odysight.ai Inc. ODYS · Entity 7081 | GrantOptions to purchase common stock (right to buy) · Derivative | 60,000 | $0.00 Strike: $4.70 | $0.00 |
DisclosureSEC source: 0001493152-26-003782 · ownership.xml · derivative · entry 1 Sagi Eilam · CIK 0002097296 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2033-01-25 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to one-third of the total shares on November 15, 2026 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on November 15, 2028. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.